Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trial.
BACKGROUND
Oral cancer is a major health problem worldwide. The 5-year survival rate ranges from 30-60%, and has remained unchanged in the past few decades. This is mainly due to late diagnosis and high recurrence of the disease. Of the patients who receive treatment, up to one third suffer from a recurrence or a second primary tumor. It is apparent that one major cause of disease recurrence is clinically unrecognized field changes which extend beyond the visible tumor boundary. We have previously developed an approach using fluorescence visualization (FV) technology to improve the recognition of the field at risk surrounding a visible oral cancer that needs to be removed and preliminary results have shown a significant reduction in recurrence rates.


METHODS
This paper describes the study design of a randomized, multi-centre, double blind, controlled surgical trial, the COOLS trial. Nine institutions across Canada will recruit a total of 400 patients with oral severe dysplasia or carcinoma in situ (N = 160) and invasive squamous cell carcinoma (N = 240). Patients will be stratified by participating institution and histology grade and randomized equally into FV-guided surgery (experimental arm) or white light-guided surgery (control arm). The primary endpoint is a composite of recurrence at or 1 cm within the previous surgery site with 1) the same or higher grade histology compared to the initial diagnosis (i.e., the diagnosis used for randomization); or 2) further treatment due to the presence of severe dysplasia or higher degree of change at follow-up. This is the first randomized, multi-centre trial to validate the effectiveness of the FV-guided surgery.


CONCLUSIONS
In this paper we described the strategies, novelty, and challenges of this unique trial involving a surgical approach guided by the FV technology. The success of the trial requires training, coordination, and quality assurance across multiple sites within Canada. The COOLS trial, an example of translational research, may result in reduced recurrence rates following surgical treatment of early-stage oral cancer with significant impacts on survival, morbidity, patients' quality of life and the cost to the health care system.


BACKGROUND
Clinicaltrials.gov NCT01039298.
Department of Oral Biological and Medical Science, The University of British Columbia, Wesbrook Mall, Vancouver, Canada. cpoh@interchange.ubc.ca
Catherine F
CF
Poh
J Scott
JS
Durham
Penelope M
PM
Brasher
Donald W
DW
Anderson
Kenneth W
KW
Berean
Calum E
CE
MacAulay
J Jack
JJ
Lee
Miriam P
MP
Rosin
D002170:Canada; D002278:Carcinoma in Situ / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D003362:Cost-Benefit Analysis; D004311:Double-Blind Method; D005453:Fluorescence; D006258:Head and Neck Neoplasms / Q000601:surgery*; D006801:Humans; D009062:Mouth Neoplasms / Q000601:surgery*; D009364:Neoplasm Recurrence, Local; D019057:Quality-Adjusted Life Years; D000077195:Squamous Cell Carcinoma of Head and Neck; D025321:Surgery, Computer-Assisted / Q000191:economics / Q000379:methods*